MedPath

A clinical trial to study the effects of Phalatrikadi kwath and Madhugrit in patients with Type 2 Diabetes Mellitus.

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2023/10/058246
Lead Sponsor
Patanjali Bhartiya Aryuvigyan evam Anusadhan Santhan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Participants will be selected irrespective of gender and socio-economic status.

2.Patients aged between 30 – 65 years.

3.Participants fulfilling the signs and symptoms of Madhumeha.

a. Prabhutmutrata (Polyuria)

b. Kar-pada daha (Burning sensation in hands and feet)

c. Kantha taalusosha (polydipsia)

d. Availa mutrata (Turbid urine)

e. Angasaad (Fatigue)

f. Mukha Madhuryasyata (Sweet taste of mouth)

g. Daurgandhaya (Foul smell)

h. Blood glucose level

i. Fasting Blood glucose from 126mg/dl to 200 mg/dl

j. Post-Prandial Blood glucose from 200 mg/dl to 300 mg/dl

k. HBA1C > 6%

Exclusion Criteria

1. Patients with Type I Diabetes (Juvenile Diabetes)

2. Patients who are taking insulin.

3. Women with Gestational Diabetes.

4. Diabetes Mellitus with Hypertension, other endocrinological diseases and any other systemic disease.

5. Diabetes Mellitus with complications such as Retinopathy, Nephropathy and Diabetic foot

6. Pregnancy and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective parameters <br/ ><br>1.Prabhoot-mutrata (Polyuria - frequency of urination) <br/ ><br>2.Kanth taalu shosh (Polydipsia – the feeling of thirst) <br/ ><br>3.Angsaad (Fatigue) <br/ ><br>4.Avilmutrata (turbid urine) <br/ ><br>5.Mukha – madhuryata (sweet taste of mouth) <br/ ><br>6.Daurgandhaya (foul smell) <br/ ><br>7.Karpada-daha (burning sensation in hand and feet) <br/ ><br> <br/ ><br>Objective parameters <br/ ><br>The objective assessment will be done on the basis of changes in the following <br/ ><br>•Fasting Blood glucose <br/ ><br>•Post-Prandial Blood glucose <br/ ><br>•Lipid Profile <br/ ><br>•Urine test for glucose <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 0 days, 30 days, 60 days, 90 days <br/ ><br>HbA1c – <br/ ><br>Time point - 0 days and 90 days <br/ ><br> <br/ ><br> <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Objective parameters <br/ ><br>The objective assessment will be done on the basis of changes in the following <br/ ><br>1. Fasting Blood glucose <br/ ><br>2. Post-Prandial Blood glucose <br/ ><br>3. Lipid Profile <br/ ><br>4. Urine test for glucose <br/ ><br>Timepoint: 0 days, 30 days, 60 days, 90 days <br/ ><br> <br/ ><br>HbA1c – <br/ ><br>Time point - 0 days & 90 days
© Copyright 2025. All Rights Reserved by MedPath